ISM2 and cancer: Even though ISM1 is reported as an endogenous angiogenesis inhibitor, it is quite the opposite that overexpression of ISM1 and ISM2 is found in the above-mentioned cancers, while it could be interesting to explore whether tight regulation over the tissue-specific expression of these proteins might play a role in cancer therapy.